Home
The Facility
Services
Our Team
Contact Us
More
Colwill K, Galipeau Y, Stuible M, Gervais C, Arnold C, Rathod B, et al. A scalable serology solution for profiling humoral immune responses to SARS-CoV-2 infection and vaccination. Clin Transl Immunology. 2022;11(3):e1380.
Cholette F, Fabia R, Harris A, Ellis H, Cachero K, Schroeder L, et al. Comparative performance data for multiplex SARS-CoV-2 serological assays from a large panel of dried blood spot specimens. Heliyon. 2022;8(9):e10270.
Collins E, Galipeau Y, Arnold C, Bosveld C, Heiskanen A, Keeshan A, et al. Cohort profile: Stop the Spread Ottawa (SSO)-a community-based prospective cohort study on antibody responses, antibody neutralisation efficiency and cellular immunity to SARS-CoV-2 infection and vaccination. BMJ Open. 2022;12(9):e062187.
Keeshan A, Galipeau Y, Heiskanen A, Collins E, McCluskie PS, Arnold C, et al. Results of the Stop the Spread Ottawa (SSO) cohort study: a Canadian urban-based prospective evaluation of antibody responses and neutralisation efficiency to SARS-CoV-2 infection and vaccination. BMJ Open. 2023;13(10):e077714.
Statistics Canada. 2023, March 27. Between April and August 2022, 98% of Canadians had antibodies against COVID-19 and 54% had antibodies from a previous infection. [Press Release]
Almeida ND, Schiller I, Ke D, Sakr E, Plesa M, Vanamala S, et al. The effect of dose-interval on antibody response to mRNA COVID-19 vaccines: a prospective cohort study. Frontiers in Immunology. 2024;15.
Anand SS, Arnold C, Bangdiwala SI, Bolotin S, Bowdish D, Chanchlani R, et al. Seropositivity and risk factors for SARS-CoV-2 infection in a South Asian community in Ontario: a cross-sectional analysis of a prospective cohort study. CMAJ Open. 2022;10(3):E599-E609.
Azeez R, Lotoski L, Dubeau A, Rodriguez N, Reyna ME, Freitas T, et al. Cohort profile: investigating SARS-CoV-2 infection and the health and psychosocial impact of the COVID-19 pandemic in the Canadian CHILD Cohort. Epidemiol Health. 2023;45:e2023091.
Bhatt M, Plint AC, Tang K, Malley R, Huy AP, McGahern C, et al. Household transmission of SARS-CoV-2 from unvaccinated asymptomatic and symptomatic household members with confirmed SARS-CoV-2 infection: an antibody-surveillance study. CMAJ Open. 2022;10(2):E357-E66.
Bhatt M, Zemek RL, Tang K, Malley R, Plint AC, Pham-Huy A, et al. Antibody Seronegativity in COVID-19 RT-PCR-Positive Children. Pediatr Infect Dis J. 2022;41(8):e318-e20.
Costiniuk CT, Singer J, Lee T, Galipeau Y, McCluskie PS, Arnold C, et al. Antibody neutralization capacity after coronavirus disease 2019 vaccination in people with HIV in Canada. AIDS. 2023;37(12):F25-F35.
Costiniuk CT, Singer J, Lee T, Langlois MA, Arnold C, Galipeau Y, et al. COVID-19 vaccine immunogenicity in people with HIV. AIDS. 2023;37(1):F1-F10.
Fakhraei R, Erwin E, Alibhai KM, Murphy MSQ, Dingwall-Harvey ALJ, White RR, et al. Prevalence of SARS-CoV-2 infection among obstetric patients in Ottawa, Canada: a descriptive study. CMAJ Open. 2022;10(3):E643-E51.
Galipeau Y, Xavier A, Dyks A, Cooper C, Langlois MA. Continuous false positive results by SARS-CoV-2 rapid antigen testing: a case report. Front Public Health. 2023;11:1240308.
Sakr E, Almeida ND, Langlois MA, Dasgupta K, Mazer BD. Booster doses of COVID-19 vaccine enhance neutralization efficiency against XBB.1.5. J Allergy Clin Immunol. 2023.
Vinh DC, Gouin JP, Cruz-Santiago D, Canac-Marquis M, Bernier S, Bobeuf F, et al. Real-world serological responses to extended-interval and heterologous COVID-19 mRNA vaccination in frail, older people (UNCoVER): an interim report from a prospective observational cohort study. Lancet Healthy Longev. 2022;3(3):e166-e75.
Whelan M, Galipeau Y, White-Al Habeeb N, Konforte D, Abou El Hassan M, Booth RA, et al. Cross-sectional Characterization of SARS-CoV-2 Antibody Levels and Decay Rates Following Infection of Unvaccinated Elderly Individuals. Open Forum Infect Dis. 2023;10(8):ofad384.
Statistics Canada. 2022, October 17. Long-term symptoms in Canadian adults who tested positive for COVID-19 or suspected an infection, January 2020 to August 2022. [Press Release]
Statistics Canada. 2021, July 06. Few Canadians had antibodies against SARS-CoV-2 in early 2021. [Press Release]
Statistics Canada. 2022, September 06. Self-reported COVID-19 test results in Canada, January 2020 to March 2022. [Press Release]
